MCL1 and hepatocellular carcinoma: In addition, miR-29 appeared to increase the rate of apoptosis in leukemia [134], hepatocellular carcinoma (HCC) [135], gastric cancer [136], lung cancer [137], and glioblastoma [138] cases through signaling via BCL-2 or myeloid leukemia cell differentiation protein 1 (MCL-1).